Literature DB >> 12599019

Ki67, gelsolin and PTEN expression in sarcomatoid renal tumors.

Harri Visapää1, David Seligson, Yunda Huang, Jian Yu Rao, Arie Belldegrun, Steve Horvath, Aarno Palotie.   

Abstract

Sarcomatoid renal tumors differ morphologically and prognostically from other renal tumors. Using tissue microarray technology, we show that sarcomatoid renal tumors have a distinct protein expression profile for biomarkers Ki67, gelsolin and PTEN, when compared with clear-cell and papillary renal tumors. Our results confirm the previous reports that Ki67 is highly expressed in sarcomatoid tumors. We also show that gelsolin expression differs between the studied tumor types, suggesting different roles for gelsolin in the carcinogenesis of different renal tumor types.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12599019     DOI: 10.1007/s00240-002-0284-z

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  6 in total

Review 1.  Epidemiology, biology and treatment of sarcomatoid RCC: current state of the art.

Authors:  Cedric Lebacle; Aydin Pooli; Thomas Bessede; Jacques Irani; Allan J Pantuck; Alexandra Drakaki
Journal:  World J Urol       Date:  2018-06-01       Impact factor: 4.226

Review 2.  Tissue microarrays: applications in urological cancer research.

Authors:  A S Merseburger; A G Anastasiadis; J Hennenlotter; D Schilling; P Simon; S A Machtens; J Serth; A Stenzl; M A Kuczyk
Journal:  World J Urol       Date:  2006-08-09       Impact factor: 4.226

3.  Phase 2 Trial of Capecitabine, Gemcitabine, and Bevacizumab in Sarcomatoid Renal-Cell Carcinoma.

Authors:  Abhishek Maiti; Maryam Nemati-Shafaee; Pavlos Msaouel; Lance C Pagliaro; Eric Jonasch; Nizar M Tannir; Amishi Y Shah
Journal:  Clin Genitourin Cancer       Date:  2017-08-10       Impact factor: 2.872

4.  A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802.

Authors:  Naomi B Haas; Xinyi Lin; Judith Manola; Michael Pins; Glenn Liu; David McDermott; David Nanus; Elisabeth Heath; George Wilding; Janice Dutcher
Journal:  Med Oncol       Date:  2011-02-06       Impact factor: 3.064

Review 5.  Sarcomatoid renal cell carcinoma: a comprehensive review of the biology and current treatment strategies.

Authors:  Brian Shuch; Gennady Bratslavsky; W Marston Linehan; Ramaprasad Srinivasan
Journal:  Oncologist       Date:  2012-01-10

6.  Long-term survival of patients with sarcomatoid renal cell cancer treated with chemotherapy.

Authors:  Janice P Dutcher; David Nanus
Journal:  Med Oncol       Date:  2010-08-18       Impact factor: 3.064

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.